GS
TLSIW icon

GTS Securities’s TriSalus Life Sciences Warrant TLSIW Stock Holding History

GTS Securities’s Portfolio TLSIW Stock Details TLSIW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,132
Closed -$13.8K – 3844
2024
Q3 		$13.8K Buy
+13,132
New +$17.7K ﹤0.01% 3973

Other funds holding TLSIW

GL
Graypoint LLC Albany, New York $1.78B AUM 16.72% 1-Year Est. Return
VI
Vestcor Inc Fredericton, New Brunswick, Canada $4.05B AUM 34.57% 1-Year Est. Return
ACM
Alpha Capital Management Austin, Texas $770M AUM 23.14% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

GTS Securities's TLSIW Position: Q4 2024 in Review

GTS Securities sold out of TriSalus Life Sciences Warrant (TLSIW) in Q4 2024, closing a stake of 13,132 shares — an estimated $13.8K sold.

GTS Securities first reported a position in TLSIW in Q3 2024 and held it in 1 quarter. The position peaked at $13.8K in Q3 2024. 8 funds tracked by Wall St. Rank hold TLSIW as of Q4 2024.

  • GTS Securities reported no remaining TriSalus Life Sciences Warrant position as of Q4 2024 after selling out during the quarter.
  • GTS Securities sold 13,132 TriSalus Life Sciences Warrant shares in Q4 2024, an estimated $13.8K.
  • GTS Securities first reported a position in TriSalus Life Sciences Warrant in Q3 2024 and held it in 1 quarter.
  • GTS Securities's TriSalus Life Sciences Warrant position peaked at $13.8K in Q3 2024.
  • 8 funds tracked by Wall St. Rank held TriSalus Life Sciences Warrant as of Q4 2024.

Based on GTS Securities's 13F filing for Q4 2024, filed 18 Feb 2025.